USPTO serial 79138724
PHF
Reviewed by CopyMark Law Group
Reg. 4676962Status 404
- Filing date
- Status date
- Registration date
- Jan 27, 2015
- Examiner
- LAVACHE, LINDA M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PHF?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
I-33170 PORDENONE (PN), IT
I-33170 PORDENONE (PN), IT
IT
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Soaps for personal use; perfumery, essential oils, cosmetics, hair lotions; dentifrices, abrasives, namely, skin abrasive preparations; scented linen water; aromatics, namely, essential oils; depilatory wax; hair dyes; cosmetic creams; deodorants for human beings or for animals; massage gels other than for medical purposes; hair spray; lotions for cosmetic purposes; lip glosses; cotton wool for cosmetic purposes; pumice stone for personal use; pomades for cosmetic purposes; potpourris in the nature of fragrances; nail care preparations; non-medicated toiletries; perfumes; air fragrancing preparations; shampoos; sunscreen preparations | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical preparations, namely, dermatological drugs, anti-infectives for systemic use, antineoplastic and immunomodulating agents, antiparasitics, systemic hormonal preparations, excluding reproductive hormones and insulins, and drugs for prevention and/or treatment of diseases or conditions related to the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genitourinary system and reproductive hormones, musculoskeletal system, nervous system, respiratory system, sensory organs; veterinary preparations for domestic, farm and marine animals, namely, dermatological drugs, anti-infectives for systemic use, antineoplastic and immunomodulating agents, antiparasitics, systemic hormonal preparations, excluding reproductive hormones and insulins, and drugs for prevention and/or treatment of diseases or conditions related to the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genitourinary system and reproductive hormones, musculoskeletal system, nervous system, respiratory system, sensory organs; sanitary preparations for medical purposes; dietary supplements adapted for medical or veterinary use, food for babies; dietary supplements for humans and animals; medical plasters; materials for dressings, namely, medical and surgical dressings; material for stopping teeth, dental wax; acids for pharmaceutical purposes, namely, amino acids; thermal water for medical purposes, namely, nutritionally fortified water; nutritional supplements; medicinal alcohol; anaesthetics; fumigating sticks; antibiotics; antioxidant pills for medical use; antiseptics; sanitary towels; bath preparations, medicated; balms for medical purposes; medicated confectionery; sticking plasters for medical use; adjuvants for medical purposes; collyrium; medicated compresses; chemical contraceptives; cultures of microorganisms for medical and veterinary use; depuratives for the body; digestives for pharmaceutical purposes; drugs for medical purposes, namely, dermatological drugs, anti-infectives for systemic use, antineoplastic and immunomodulating agents, antiparasitics, systemic hormonal preparations, excluding reproductive hormones and insulins, and drugs for prevention and/or treatment of diseases or conditions related to the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genitourinary system and reproductive hormones, musculoskeletal system, nervous system, respiratory system, sensory organs; medicinal herbs; medicinal fungi; meal for pharmaceutical purposes; febrifuges; milk ferments for pharmaceutical purposes; chewing gum for medical purposes; insecticides; insect repellents; dietary and nutritional supplements; vitamin supplement products, namely, vitamin supplements; mineral food supplements; nutritional supplements for medical purposes; protein dietary supplements; mineral food supplements; laxatives; skin lotions for pharmaceutical purposes; skin lotions for veterinary purposes; medicines for human purposes, namely, dermatological drugs, anti-infectives for systemic use, antineoplastic and immunomodulating agents, antiparasitics, systemic hormonal preparations, excluding reproductive hormones and insulins, and medicines for prevention and/or treatment of diseases or conditions related to the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genitourinary system and reproductive hormones, musculoskeletal system, nervous system, respiratory system, sensory organs; medicines for dental purposes; medicines for veterinary purposes for domestic, farm and marine animals, namely, dermatological drugs, anti-infectives for systemic use, antineoplastic and immunomodulating agents, antiparasitics, systemic hormonal preparations, excluding reproductive hormones and insulins, and drugs for prevention and/or treatment of diseases or conditions related to the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genitourinary system and reproductive hormones, musculoskeletal system, nervous system, respiratory system, sensory organs; serotherapeutic medicines; medicinal oils; royal jelly dietary supplements; parasiticides; lozenges for pharmaceutical purposes; pesticides; medical slimming pills; pomades for medical purposes; biological preparations for veterinary purposes, for domestic, farm and marine animals, namely, dermatological drugs, anti-infectives for systemic use, antineoplastic and immunomodulating agents, antiparasitics, systemic hormonal preparations, excluding reproductive hormones and insulins, and biological preparations for prevention and/or treatment of diseases or conditions related to the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genitourinary system and reproductive hormones, musculoskeletal system, nervous system, respiratory system, sensory organs; chemical preparations for pharmaceutical purposes, namely, dermatological drugs, anti-infectives for systemic use, antineoplastic and immunomodulating agents, antiparasitics, systemic hormonal preparations, excluding reproductive hormones and insulins, and drugs for prevention and/or treatment of diseases or conditions related to the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genitourinary system and reproductive hormones, musculoskeletal system, nervous system, respiratory system, sensory organs; chemical preparations for medical purposes, namely, dermatological drugs, anti-infectives for systemic use, antineoplastic and immunomodulating agents, antiparasitics, systemic hormonal preparations, excluding reproductive hormones and insulins, and drugs for prevention and/or treatment of diseases or conditions related to the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genitourinary system and reproductive hormones, musculoskeletal system, nervous system, respiratory system, sensory organs; chemical preparations for veterinary purposes, namely, dermatological drugs, anti-infectives for systemic use, antineoplastic and immunomodulating agents, antiparasitics, systemic hormonal preparations, excluding reproductive hormones and insulins, and drugs for prevention and/or treatment of diseases or conditions related to the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genitourinary system and reproductive hormones, musculoskeletal system, nervous system, respiratory system, sensory organs; bacterial preparations for medical and veterinary use; bacteriological preparations for medical and veterinary use; vitamin preparations; hemorrhoid treatment preparations; antiparasitic preparations; mothproofing preparations; anti-uric preparations; biological preparations, namely, dermatological drugs, anti-infectives for systemic use, antineoplastic and immunomodulating agents, antiparasitics, systemic hormonal preparations, excluding reproductive hormones and insulins, and biological preparations for prevention and/or treatment of diseases or conditions related to the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genitourinary system and reproductive hormones, musculoskeletal system, nervous system, respiratory system, sensory organs; pharmaceutical preparations for skin care; diagnostic preparations for medical purposes; air purifying preparations; radioactive substances for medical purposes; sodium salts for medical purposes; medicated serums for treatment of skin, lips, hair; soporifics; radiological contrast substances for medical purposes; dietetic substances adapted for medical use, namely, dietary supplements; herbal teas for medicinal purposes; vaccines; vermifuges, namely, medicines for expelling intestinal worms | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, pharmaceutical, chemical, biotechnology research and development; industrial analysis and research services in the fields of pharmaceutical and cosmetics; chemical analysis; material testing; industrial design; designing and conducting geological surveys; conducting clinical trials for others; geological prospecting; biological research; geological research; bacteriological research; chemical research; cosmetic research; physics research; research in the field of environmental protection; mechanical research; scientific research; technical research in the fields of pharmaceuticals, chemicals, and biotechnologies; chemistry services, namely, chemistry research and chemistry consultation; scientific laboratory services | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by HOLDING F.I.S. S.P.A.
- Other trademarks owned by HOLDING F.I.S. S.P.A.
- Other trademarks owned by NINE TREES GROUP S.P.A.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named PHF
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 12, 2024 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Jan 12, 2024 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Aug 15, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 23, 2022 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jul 23, 2022 | INPC | INVALIDATION PROCESSED | — |
| Apr 13, 2022 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 3, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 13, 2021 | C71T | CANCELLED SECTION 71 | — |
| Aug 1, 2019 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jun 20, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 1, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 1, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 31, 2015 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Apr 27, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 27, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 11, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 8, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 22, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 22, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 22, 2014 | NPUB | NOTICE OF PUBLICATION | — |
| Oct 6, 2014 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Oct 4, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 4, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 4, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 4, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 3, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 3, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 3, 2014 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 8, 2014 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 8, 2014 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 13, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 13, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 4, 2014 | ALIE | ASSIGNED TO LIE | — |
| May 22, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 25, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 4, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 4, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 1, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 30, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 26, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 22, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 22, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 21, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |